Results 201 to 210 of about 26,590 (287)

Diagnosis and management of neutropenia in adults: Expert guidance

British Journal of Haematology, Volume 209, Issue 2, Page 432-440, August 2026.
Severe neutropenia can result from decreased production of neutrophil precursors in the bone marrow, as in the case of severe congenital neutropenia, or from increased utilization of neutrophils or their accelerated destruction as for drug‐induced neutropenia or autoimmune neutropenia. Severe chronic neutropenia increases susceptibility to bacterial or
Karl Welte, Cornelia Zeidler, Julia Skokowa, Sabine Mellor‐Heineke, Audrey Anna Bolyard, David Dale   +5 more
wiley   +1 more source

High‑altitude polycythemia: Unveiling the molecular landscape beyond erythropoietin (Review). [PDF]

Int J Mol Med
Li H, Zhang H, Zhang H, Li Y, He Y, Luan J.   +5 more
europepmc   +1 more source

Evaluating high‐sensitivity troponin levels in people with sickle cell disease in the emergency department

British Journal of Haematology, Volume 209, Issue 2, Page 833-836, August 2026.
This study shows that sickle cell disease patients have elevated high‐sensitivity cardiac troponin I (hs‐cTnI) that is not considered clinically significant but are outside of the normal range. Elevated hs‐cTnI was associated with low haemoglobin and a history of heart failure.
Abdelrhman Mohammed, Najibah A. Galadanci, Gerhard Hellemann, Julie Kanter   +3 more
wiley   +1 more source

Mitochondrial dysfunction-induced hemolysis: a precursor to vascular leakage and pulmonary hypertension. [PDF]

Blood Vessel Thromb Hemost
James J, Niihori M, Varghese MV, McClain N, Rafikova O, Rafikov R.   +5 more
europepmc   +1 more source

Bone Marrow Pathology in Cold Agglutinin‐Mediated Autoimmune Hemolytic Anemia: A Study of 56 Cases

European Journal of Haematology, Volume 117, Issue 2, Page 384-395, August 2026.
ABSTRACT Cold agglutinin disease (CAD) is a rare form of autoimmune hemolytic anemia (AIHA). CAD occurs in the context of a small clonal B‐cell lymphoproliferation restricted to blood and/or bone marrow (BM), without overt or extramedullary lymphoma. The WHO‐HAEM5 introduced a description of the CAD‐associated lymphoproliferative disorder (CAD‐LPD) in ...
Anne‐Marie L. Becking, Sophie J. Bernelot Moens, Marie José Kersten, Femke V. M. Mulder, Steven T. Pals, Lianne Koens, Josephine M. I. Vos   +6 more
wiley   +1 more source

Anemia of Chronic Disease Revisited: Hepcidin Dysregulation, Erythropoietic Failure, and Emerging Roles of SGLT2 Inhibition

European Journal of Haematology, Volume 117, Issue 2, Page 296-304, August 2026.
ABSTRACT Anemia of chronic disease (ACD), also referred to as anemia of inflammation, is a prevalent and clinically significant complication of chronic infection, autoimmune disease, malignancy, and chronic kidney disease. It is characterized by inflammation‐driven iron sequestration, impaired erythropoietin (EPO) production and signaling, and ...
Mohammed Abdulgayoom, Awni Alshurafa, Rasha Kaddoura, Abdulrahman F. Al‐Mashdali, Shehab F. Mohamed, Mohamed A. Yassin   +5 more
wiley   +1 more source

Time stability of Intensive Care Infection Score (ICIS) as a cellular hematology biomarker for infection in critically ill patients. [PDF]

Sci Rep
Nacke N, Zuther M, Hönemann C, Zimmermann M, Blömer B, Klatte S, Schewe JC, Rübsam ML.   +7 more
europepmc   +1 more source

Analytical and Clinical Performance of the Atellica HEMA 580 Haematology Analyzer: A Comparison With the ADVIA 2120i

International Journal of Laboratory Hematology, Volume 48, Issue 4, Page 784-794, August 2026.
ABSTRACT Introduction The Atellica HEMA 580 is a novel haematology analyser providing eight‐part leukocyte differential and optical platelet (PLT) counting. We compared its analytical and clinical performance with that of the ADVIA 2120i. Methods A total of 796 residual whole blood specimens were analysed.
Hyeongyu Lee, Jooyoung Cho, Gilsung Yoo, Juwon Kim   +3 more
wiley   +1 more source

Renal complications in pediatric sickle cell disease: results from a single-center study. [PDF]

Ann Hematol
Marchesani S, Antonucci L, Scaramuzzino F, Schettini L, Di Mauro M, Fini F, Palumbo G, Ceglie G.   +7 more
europepmc   +1 more source

Safety and tolerability of amustaline/glutathione pathogen‐reduced red blood cells in neonatal rats

Transfusion, Volume 66, Issue 8, Page 1603-1612, August 2026.
Abstract Background Amustaline (S‐303)/glutathione (GSH) pathogen‐reduced red blood cells (PR‐RBCs) are in development for all adult and pediatric RBC transfusion indications, including neonates and infants. A neonatal rat model evaluated the safety and tolerability of PR‐RBCs during growth and maturation. Study Design and Methods Repeated transfusions
Anne North, Laurence Corash, Richard J. Benjamin, Nina Mufti   +3 more
wiley   +1 more source